Suchergebnisse - "Yamada, Tadaaki"

PubPharm (20)

1

Impact of docetaxel plus ramucirumab in a second-line setting after chemoimmunotherapy in patients with non-small-cell lung cancer : A retrospective study

enthalten in: Thoracic cancer | 2022

von Ishida, M. | Morimoto, K. | Yamada, T. | +9

2

Significance of inflammatory indexes in atezolizumab monotherapy outcomes in previously treated non-small-cell lung cancer patients

enthalten in: Scientific reports | 2020

von Katayama, Y. | Yamada, T. | Chihara, Y. | +15

3

Osimertinib in Elderly Patients with Epidermal Growth Factor Receptor T790M-Positive Non-Small-Cell Lung Cancer Who Progressed During Prior Treatment : A Phase II Trial

enthalten in: The oncologist | 2019

von Nakao, A. | Hiranuma, O. | Uchino, J. | +26

4

Pulmonary carcinosarcoma showing an obvious response to pazopanib : a case report

enthalten in: BMC pulmonary medicine | 2018

von Tanimoto, A. | Takeuchi, S. | Kotani, H. | +6

5

Treatment rationale and design of the RAMNITA study : A phase II study of the efficacy of docetaxel + ramucirumab for non-small cell lung cancer with brain metastasis

enthalten in: Medicine | 2018

von Tanimura, K. | Uchino, J. | Tamiya, N. | +4

6

In vivo imaging xenograft models for the evaluation of anti-brain tumor efficacy of targeted drugs

enthalten in: Cancer medicine | 2017

von Kita, K. | Arai, S. | Nishiyama, A. | +12

7

MET Copy Number Gain Is Associated with Gefitinib Resistance in Leptomeningeal Carcinomatosis of EGFR-mutant Lung Cancer

enthalten in: Molecular cancer therapeutics | 2017

von Nanjo, S. | Arai, S. | Wang, W. | +6

8

Therapeutic activity of glycoengineered anti-GM2 antibodies against malignant pleural mesothelioma

enthalten in: Cancer science | 2015

von Li, Q. | Wang, W. | Machino, Y. | +12

9

Antitumor effect and antiangiogenic potential of the mTOR inhibitor temsirolimus against malignant pleural mesothelioma

enthalten in: Oncology reports | 2014

von Moriya, M. | Yamada, T. | Tamura, M. | +7

10

Synchronous triple cancers of the pancreas, stomach, and cecum treated with S-1 followed by pancrelipase treatment of pancreatic exocrine insufficiency

enthalten in: JOP : Journal of the pancreas | 2013

von Ohtsubo, K. | Ishikawa, D. | Nanjo, S. | +11